<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Dr Bilal Malik — Publications & Talks</title>

  <style>
    body {
      background: #0f172a;
      color: #e5e7eb;
      font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
      max-width: 1100px;
      margin: auto;
      padding: 30px;
      line-height: 1.6;
    }

    h1 { color: #38bdf8; margin-bottom: 6px; }
    h2 { color: #60a5fa; margin-top: 26px; }

    a { color: #38bdf8; text-decoration: none; }
    a:hover { text-decoration: underline; }

    small { opacity: 0.85; }

    .card {
      background: #111827;
      padding: 18px;
      border-radius: 10px;
      margin-top: 12px;
      border: 1px solid rgba(255,255,255,0.08);
    }

    ul { padding-left: 18px; }
    li { margin-bottom: 10px; }

    .toplinks {
      margin-top: 10px;
      margin-bottom: 20px;
      opacity: 0.95;
    }

    .section { margin-top: 18px; }
    .banner {
      max-width: 520px;
      width: 100%;
      border-radius: 12px;
      display: block;
      margin: 0 auto 18px auto;
    }

    hr {
      border: none;
      border-top: 1px solid rgba(255,255,255,0.10);
      margin: 22px 0;
    }
  </style>
</head>

<body>

  <div style="text-align:center;margin:0 0 16px 0;">
    <img src="image2.png" alt="Bilal Malik — Research Outputs & Publications" class="banner">
  </div>

  <h1>Publications & Talks</h1>
  <small>Full list of outputs associated with the SBMA/ALS4 research programme and MyoNeuroTwin platform.</small>

  <div class="toplinks">
    <a href="index.html">Back to MULLIX</a> |
    <a href="outputs_final.html">Programme Summary</a> |
    <a href="https://scholar.google.com/citations?user=VEkY9VIAAAAJ&hl=en" target="_blank" rel="noopener">Google Scholar</a>
  </div>

  <h2>Peer-Reviewed Publications (Full List)</h2>

  <div class="card">
    <div class="section">
      <h2>Publications</h2>
      <ul>
        <li>Devine, H., Roberts, M. J., Ziff, O. J., Hanna, M. G., Greensmith, L., Patani, R. & Malik, B*. Conserved Aberrant Developmental Trajectories of Human and Mouse SBMA Motor Neurons. bioRxiv, 2025.2009.2017.674754, doi:10.1101/2025.09.17.674754 (2025). *Senior Author</li>
        <li>Villarroel-Campos, D., Rhymes, E. R., Tosolini, A. P., Malik, B., Vagnoni, A., Schiavo, G. & Sleigh, J. N. Processivity and BDNF-dependent modulation of signalling endosome axonal transport are impaired in aged mice. bioRxiv, 2025.2001.2030.635507, doi:10.1101/2025.01.30.635507 (2025).</li>
        <li>Pennuto, M., Pradat, P. F., Soraru, G., Greensmith, L. & Consortium, K. D. 271st ENMC international workshop: Towards a unifying effort to fight Kennedy's disease. 20-22 October 2023, Hoofddorp, Netherlands. Neuromuscul Disord 38, 8-19, doi:10.1016/j.nmd.2024.03.003 (2024).</li>
        <li>Forouhan, M., Lim, W. F., Zanetti-Domingues, L. C., Tynan, C. J., Roberts, T. C., Malik, B., Manzano, R., Speciale, A. A., Ellerington, R., Garcia-Guerra, A., Fratta, P., Soraru, G., Greensmith, L., Pennuto, M., Wood, M. J. A. & Rinaldi, C. AR cooperates with SMAD4 to maintain skeletal muscle homeostasis. Acta Neuropathol 143, 713-731, doi:10.1007/s00401-022-02428-1 (2022).</li>
        <li>Lombardi, V., Bombaci, A., Zampedri, L., Lu, C. H., Malik, B., Zetterberg, H., Heslegrave, A. J., Rinaldi, C., Greensmith, L., Hanna, M. G., Malaspina, A. & Fratta, P. Plasma pNfH levels differentiate SBMA from ALS. J Neurol Neurosurg Psychiatry 91, 215-217, doi:10.1136/jnnp-2019-320624 (2020).</li>
        <li>Gray, A. L., Annan, L., Dick, J. T., La Spada, A. R., Hanna, M. G., Greensmith, L. and Malik, B*. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice. Dis Model Mech. doi:10.1242/dmm.042424 (2020). *Senior Author</li>
        <li>Lombardi V, Querin G, Ziff OJ, Zampedri L, Martinelli I, Heller C, Foiani M, Bertolin C, Lu CH, Malik B, Allen K, Rinaldi C, Zetterberg H, Heslegrave A, Greensmith L, Hanna M, Soraru G, Malaspina A, Fratta P. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy. Neurology. 2019 Mar 12;92(11):e1205-e1211.</li>
        <li>Malik B, Devine H, Patani R, La Spada AR, Hanna MG, Greensmith L. Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy. Sci Rep. 2019 Mar 5;9(1):3539</li>
        <li>Bennett CL, Dastidar SG, Ling SC, Malik B, et al. Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients. Acta Neuropathol. 2018 Sep;136(3):425-443.</li>
        <li>Luisier R, Tyzack GE, Hall CE, Mitchell JS, Devine H, Taha DM, Malik B, et al. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat Commun. 2018 May 22;9(1):2010.</li>
        <li>Rinaldi C, Malik B, Greensmith L. Targeted molecular therapies for SBMA. J Mol Neurosci. 2016;58(3):335-42.</li>
        <li>Rusmini R, Crippa V, Cristofani R, Rinaldi C, Carra S, Malik B, Greensmith L, Poletti A. The Role of the Protein Quality Control System in SBMA. J Mol Neurosci. 2016;58(3):348-64.</li>
        <li>Montague K, Malik B, Gray AL, La Spada AR, Hanna MG, Szabadkai G, Greensmith L. Endoplasmic reticulum stress in Spinal and Bulbar Muscular Atrophy–a potential target for therapy. Brain. 2014;137(Pt 7):1894-906.</li>
        <li>Malik B, Nirmalananthan N, Gray AL, La Spada AR, Hanna MG, Greensmith L. Co-induction of the heat shock response ameliorates disease progression in a mouse model of SBMA. Brain. 2013;136(Pt 3):926-43.</li>
        <li>Malik B, Fernandes C, Killick R, et al. Oligomeric amyloid-β peptide regulates genes involved in steroid and lipid metabolism in primary neurons. Neurochem Int. 2012;61(3):321-33.</li>
        <li>Killick R, Ribe EM, Al-Shawi R, Malik B, et al. Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway. Mol Psychiatry. 2012.</li>
        <li>Malik B, Currais A, Andres A, et al. Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain. Cell Cycle. 2008;7(5):637-46.</li>
      </ul>
    </div>

    <hr>

    <div class="section">
      <h2>Invited Talks</h2>
      <ul>
        <li>2024. 271st ENMC international workshop: Towards a unifying effort to fight Kennedy's disease. 20-22 October 2023, Hoofddorp, Netherlands.</li>
        <li>2022. Invited External Speaker: Kennedy’s Association and KD-UK Patient Day (10-7-22). “Investigating Disease Pathways and Novel Therapeutic Targets in Kennedy’s Disease.”</li>
        <li>2022. National Brain Bee Judge & Speaker (29-5-22). “Careers in Neuroscience – Academic Research, Neurodegeneration and Motor Neuron Disease.”</li>
        <li>2021. Kennedy’s Disease Association (USA) Conference. “Investigating disease pathways and novel therapeutic targets in SBMA.”</li>
        <li>2021. International SBMA Research Conference. “Early deterioration and targeting of muscle function as a therapeutic strategy for SBMA.”</li>
        <li>2019. 241st ENMC international workshop, Hoofddorp, Netherlands. “Investigating Disease Pathways to Establish Therapeutic Targets in SBMA.”</li>
        <li>2019. UCL IoN Neuromuscular Diseases Annual Research Day. “Investigating disease pathways to establish novel therapeutic targets in SBMA.”</li>
        <li>2018. IV Italian meeting on Kennedy’s disease, University of Padova. “Investigating Disease Pathways in SBMA.”</li>
        <li>2017. 1st Kennedy’s Disease Patient Day. “Investigating Disease Pathways using Models of Kennedy’s Disease.”</li>
      </ul>
    </div>
  </div>

  <h2>Notes</h2>
  <div class="card">
    <p>For the most current list, see Google Scholar. You can also email for an updated CV.</p>
  </div>

</body>
</html>